These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 571917)

  • 41. Is conformational analysis a key to solve the structure--activity problem of neuroleptics?
    Misztal S; Mokrosz JL
    Pharmazie; 1986 Apr; 41(4):277-81. PubMed ID: 2425381
    [No Abstract]   [Full Text] [Related]  

  • 42. Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity.
    Froimowitz M; Rämsby S
    J Med Chem; 1991 May; 34(5):1707-14. PubMed ID: 1674541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-Chloro-2-phenyl-1-benzo[b]thiophene-3-alkanimines, potential antipsychotic agents.
    Kukla MJ; Woo CM; Kehr JR; Miller A
    J Med Chem; 1978 Apr; 21(4):348-52. PubMed ID: 25967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine receptors in the central nervous system.
    Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
    Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437.
    Timmerman W; Tepper PG; Bohus BG; Horn AS
    Eur J Pharmacol; 1990 Jun; 181(3):253-60. PubMed ID: 1974516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD; Harting J; Minck KO
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of blockade of dopamine receptors on the inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats.
    Gallo RV
    Endocrinology; 1978 Apr; 102(4):1026-35. PubMed ID: 744005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Place-aversion conditioned by phencyclidine in rats: development of tolerance and pharmacologic antagonism.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(4):265-76. PubMed ID: 2418852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antipsychotic activity of substituted gamma-carbolines.
    Abou-Gharbia M; Patel UR; Webb MB; Moyer JA; Andree TH; Muth EA
    J Med Chem; 1987 Oct; 30(10):1818-23. PubMed ID: 2888898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is dopamine antagonism a requisite of neuroleptic activity?
    Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential sensitivity to neuroleptic drugs of cerebral dopamine receptors following chronic treatment of rats with trifluoperazine.
    Dawbarn D; Pycock C
    Eur J Pharmacol; 1981 May; 71(2-3):233-45. PubMed ID: 6113967
    [No Abstract]   [Full Text] [Related]  

  • 53. Binding of 5H-dibenzo[a,d]cycloheptene and dibenz[b,f]oxepin analogues of clozapine to dopamine and serotonin receptors.
    Phillips ST; de Paulis T; Neergaard JR; Baron BM; Siegel BW; Seeman P; Van Tol HH; Guan HC; Smith HE
    J Med Chem; 1995 Feb; 38(4):708-14. PubMed ID: 7861418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium-dependent interaction of benzamides with dopamine receptors in rat and dog anterior pituitary glands.
    Stefanini E; Clément-Cormier Y; Vernaleone F; Devoto P; Marchisio AM; Collu R
    Neuroendocrinology; 1981 Feb; 32(2):103-7. PubMed ID: 6163103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral and neurochemical modifications induced by apomorphine treatment.
    Piervincenzo P; Luciana G; Laura C; Giuseppe A
    Neurosci Lett; 1989 May; 100(1-3):265-70. PubMed ID: 2761776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localization of dopamine receptors in rat brain.
    Reisine TD; Nagy JI; Fibiger HC; Yamamura HI
    Brain Res; 1979 Jun; 169(1):209-14. PubMed ID: 455093
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
    Marshall AM; Mishra RK
    Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
    Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 60. Design, synthesis, and X-ray data of novel potential antipsychotic agents. Substituted 7-phenylquinolizidines: stereospecific, neuroleptic, and antinociceptive properties.
    Imhof R; Kyburz E; Daly JJ
    J Med Chem; 1984 Feb; 27(2):165-75. PubMed ID: 6198519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.